The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker

Cell Mol Neurobiol. 2022 Oct;42(7):2147-2156. doi: 10.1007/s10571-021-01115-1. Epub 2021 Jun 12.

Abstract

There has been an increase in the incidence of chronic neurodegenerative disorders of the central nervous system, including Alzheimer's and Parkinson's diseases, over the recent years mostly due to the rise in the number of elderly individuals. In addition, various neurodegenerative disorders are related to imbalances in the CXCL12/CXCR4/ACKR3 response axis. Notably, the CXC Chemokine Ligand 12 (CXCL12) is essential for the development of the central nervous system. Moreover, the expression and distribution of CXCL12 and its receptors are associated with the aggravation or alleviation of symptoms of neurodegenerative disorders. Therefore, the current review sought to highlight the specific functions of CXCL12 and its receptors in various neurodegenerative disorders, in order to provide new insights for future research.

Keywords: ACKR3; CXCL12; CXCR4; Central nervous system; Neurodegenerative disorders.

Publication types

  • Review

MeSH terms

  • Aged
  • Biomarkers
  • Central Nervous System
  • Chemokine CXCL12*
  • Humans
  • Ligands
  • Receptors, CXCR*
  • Receptors, CXCR4
  • Signal Transduction

Substances

  • Biomarkers
  • CXCL12 protein, human
  • CXCR4 protein, human
  • Chemokine CXCL12
  • Ligands
  • Receptors, CXCR
  • Receptors, CXCR4